CORO1C and gastric cancer: As illustrated in Table 2, gastric cancer patients with positive CORO1C expression exhibited a higher risk of lymph node metastasis (P = 0.005) and a worse clinical stage (P = 0.024) compared with patients with negative CORO1C expression.